Equities

Next Science Ltd

Next Science Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (AUD)0.135
  • Today's Change-0.007 / -5.26%
  • Shares traded10.70k
  • 1 Year change-48.08%
  • Beta1.9601
Data delayed at least 20 minutes, as of Nov 22 2024 04:59 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Next Science Limited is an Australia-based medical technology company. The Company’s primary focus is on the development and commercialization of its proprietary XBIO technology to reduce the impact of biofilm-based infections on human health. XBIO is a non-toxic technology with an efficacy in eradicating both biofilm-based and free-floating bacteria. The Company’s products include XPERIENCE, Blast X, SurgX and Bactisure. The XPERIENCE product is an antimicrobial solution used to prevent surgical site infections by rinsing away debris and microorganisms. SurgX Sterile Antimicrobial Gel is used to reduce surgical site and post-surgical infections by destroying planktonic and biofilm-based bacteria within the gel with sustained effectiveness for up to five days. BLASTX Antimicrobial Wound Gel provides wound management by maintaining a moist wound environment, which is conducive to wound healing.

  • Revenue in AUD (TTM)35.84m
  • Net income in AUD-20.76m
  • Incorporated2017
  • Employees--
  • Location
    Next Science LtdTower BThe Zenith L 19, 821 Pacific HighwayChatswood 2000AustraliaAUS
  • Phone+61 28607-5124
  • Websitehttps://www.nextscience.com
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Nyrada Inc3.40m-1.39m22.01m----3.79--6.47-0.0081-0.00810.02090.02770.6147-------25.13-53.28-29.75-62.52-----40.89-236.15----0.00--115.5546.4282.12------
Oncosil Medical Ltd583.20k-11.91m31.32m2.00--4.92--53.70-0.0054-0.00540.00030.00140.0641--3.12---130.97-67.66-162.31-77.45-158.87---2,042.81-768.23----0.0147--35.54-31.37-5.03--67.76--
Little Green Pharma Ltd25.63m-8.15m39.37m----0.505--1.54-0.0272-0.02720.08560.25740.27721.0512.29---8.82---9.74--53.18---31.81--1.39-18.900.0624--29.07--4.72------
Next Science Ltd35.84m-20.76m41.63m----3.82--1.16-0.0773-0.07730.13150.03731.975.348.04---113.88-74.40-168.92-90.3178.8376.98-57.93-128.261.96--0.1045--89.3650.80-28.29---2.28--
Medical Developments International Ltd33.15m-40.99m47.88m68.00--0.8234--1.44-0.4627-0.46270.37410.51620.41311.024.14---51.09-15.81-60.56-17.7973.5070.98-123.66-52.491.82--0.0476--2.519.22-630.83---20.32--
Starpharma Holdings Ltd9.76m-8.17m48.08m50.00--1.69--4.93-0.0198-0.01980.02370.06820.21950.2441.20---18.37-27.20-24.10-33.0593.5277.48-83.69-269.744.58--0.1115--131.8429.1047.79---22.29--
Inoviq Ltd791.70k-6.55m49.63m85.00--2.35--62.69-0.0709-0.07090.00860.18940.03664.540.6418---30.33-44.62-32.64-47.5589.77---827.88-1,928.527.06--0.0198--5.29146.3326.92------
Vitura Health Ltd123.87m3.51m56.44m119.0015.881.4611.550.45560.00620.00620.21650.06742.1015.0410.741,040,932.005.5013.507.7018.5127.6332.412.626.191.1130.480.2228--5.56---74.57--155.80--
Radiopharm Theranostics Ltd299.23k-47.95m56.50m----0.4256--188.81-0.1261-0.12610.00080.06110.0041--0.1097---65.24---82.85-------16,024.17-----3.910.00--2.35---38.54------
Syntara Ltd5.43m-13.67m57.67m107.00--10.72--10.62-0.0157-0.0160.00570.00390.3155--0.7918---79.44-30.68-130.63-40.26-----251.77-74.66---484.900.0474---7.92-15.43-1.77---62.79--
Data as of Nov 22 2024. Currency figures normalised to Next Science Ltd's reporting currency: Australian Dollar AUD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.